Metoprolol tartrate vs metoprolol succinate efficacy
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Metoprolol Tartrate vs Metoprolol Succinate in Cardiovascular Conditions
Heart Failure: Clinical and Hemodynamic Outcomes
Multiple studies have compared metoprolol tartrate and metoprolol succinate in patients with chronic congestive heart failure. Both forms show similar effects on cardiac function, including left ventricular dimensions and ejection fraction, as well as on renal function markers like BUN and creatinine. However, metoprolol succinate tends to lower average heart rate more effectively than metoprolol tartrate in these patients, suggesting a possible advantage in heart rate control Feng-Qi2014Quan-Y2013. In terms of hemodynamic benefits, both formulations provide comparable improvements in functional status, exercise capacity, and hemodynamic parameters such as cardiac index and stroke volume index, with no significant differences between the two .
Angina and Cardiovascular Events
In patients with vasospastic angina, metoprolol succinate was associated with fewer clinically significant angina attacks compared to metoprolol tartrate. However, there were no significant differences between the two in terms of major cardiovascular events such as myocardial infarction, stroke, or cardiovascular death . This suggests that while both forms are similarly effective in preventing serious outcomes, succinate may offer better symptom control for angina.
Hypertension: Blood Pressure and Heart Rate Variability
For mild hypertension, both metoprolol tartrate and metoprolol succinate are effective in lowering blood pressure. The sustained-release (succinate) formulation may provide additional benefits by reducing the morning blood pressure peak and increasing heart rate variability, which could be advantageous for long-term cardiovascular risk management .
Pharmacokinetics and Dosing Convenience
Metoprolol succinate, as a controlled-release formulation, maintains steadier plasma concentrations throughout the day, avoiding the peaks and troughs seen with immediate-release metoprolol tartrate. This results in a more consistent beta-blocking effect, especially over a 24-hour period, and may improve adherence due to once-daily dosing compared to the twice-daily regimen required for tartrate . Both forms, however, have similar overall efficacy when dosed appropriately.
Safety and Tolerability
Both metoprolol tartrate and succinate have similar safety profiles, with no significant differences in adverse drug reactions reported across studies. This holds true even in patients with comorbid conditions such as chronic obstructive pulmonary disease and heart failure .
Summary of Comparative Efficacy
- Both metoprolol tartrate and succinate are effective for heart failure, hypertension, and angina, with similar impacts on major clinical outcomes Bocharov2021Kukin2000Feng-Qi2014+2 MORE.
- Metoprolol succinate may offer advantages in heart rate control, reduction of angina attacks, and more stable drug levels, which can improve symptom management and convenience Bocharov2021Feng-Qi2014Quan-Y2013+2 MORE.
- Safety profiles are comparable between the two formulations Kukin2000Li-Gan2015.
Conclusion
Metoprolol tartrate and metoprolol succinate are both effective beta-blockers for cardiovascular conditions. While their overall efficacy in preventing major events is similar, metoprolol succinate may provide better symptom control, heart rate management, and dosing convenience due to its sustained-release properties. Both formulations are safe and well-tolerated when used as indicated.
Sources and full results
Most relevant research papers on this topic
Comparative evaluation of the effectiveness of metoprolol succinate and metoprolol tartrate in patients with vasospastic angina
Metoprolol succinate has a significant advantage in reducing clinically significant angina attacks, but no significant difference in cardiovascular events or death between the two drugs.
Comparision of Metoprolol Succinate Sustained-release Tablets and Metoprolol Tartrate Tablets on Cardiac Function in Patients with Chronic Congestive Heart Failure
Metoprolol succinate sustained-release tablets decreased average heart rate in chronic congestive heart failure patients compared to Metoprolol tartrate tablets, with equal effects on cardiac and renal function.
Clinical Observation of Two Dosage Forms of Metoprolol in the Treatment of Chronic Obstructive Pulmonary Disease Complicating with Chronic Heart Failure
Metoprolol succinate sustained-release tablet is more effective than Metoprolol tartrate tablet in improving cardiac function in COPD patients with chronic heart failure, but both have similar safety.
Clinical comparison between two formulations of metoprolol in the treatment of mild hypertension
Metoprolol sustained-release form effectively reduces peak morning blood pressure and increases heart rate variability compared to metoprolol tartrate form in treating mild hypertension.
WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL
Metoprolol's clinical efficacy depends on its molecule, not its salts or drug presentation, and its effectiveness in treating arterial hypertension, unstable angina, myocardial infarction, and heart failure remains unchanged.
DOI